What happens when you take niacin with coq10?
Niacin (vitamin B3) is the dietary precursor to NAD+ and NADH, the universal electron carriers used in cellular respiration. NADH delivers electrons into Complex I of the mitochondrial electron transport chain. From Complex I, CoQ10 picks up those electrons and shuttles them to Complex III, which eventually drives the proton gradient that powers ATP synthesis. In other words, the two nutrients sit at adjacent steps of the same energy-producing assembly line.
Supplementing niacin (as nicotinic acid, nicotinamide, or nicotinamide riboside) raises cellular NAD+ levels, which is the limiting substrate for many redox enzymes and for NAD-consuming proteins such as sirtuins and PARPs. Supplementing CoQ10 (especially ubiquinol) raises mitochondrial pool size and supports the electron transport chain itself. A 2021 review in Antioxidants on CoQ10 in cardiovascular disease describes its essential role in mitochondrial energy metabolism and as an endogenous antioxidant, complementing other mitochondrial cofactors.
The two work together: more NAD+ from niacin means more raw fuel for the electron transport chain, and more CoQ10 means more capacity to actually move those electrons through the chain to produce ATP.
Why is this important?
NAD+ levels fall steeply with age, and CoQ10 levels also decline after age 30 to 40. Together this contributes to reduced mitochondrial output, which is linked to fatigue, cognitive slowing, and cardiovascular dysfunction. Statin therapy further depletes CoQ10 by blocking the mevalonate pathway, making CoQ10 supplementation particularly relevant for that group.
However, there is an important caveat with high-dose niacin in combination with statins. Studies such as AIM-HIGH and HPS2-THRIVE found that prescription-strength niacin added to statin therapy did not reduce cardiovascular events and increased side effects, including significantly elevated risk of myopathy. This is a statin-niacin interaction, not a CoQ10 interaction, but it is the main reason therapeutic-dose niacin is no longer routinely used as cardiovascular therapy.
Low-dose nicotinamide and nicotinamide riboside, used as NAD+ precursors at 250 to 500 mg, do not produce the flush, the hepatotoxicity, or the myopathy risk associated with gram-doses of nicotinic acid.
What should you do?
For general mitochondrial and energy support, a sensible regimen is 250 to 500 mg of nicotinamide or nicotinamide riboside paired with 100 to 200 mg of CoQ10 (preferably ubiquinol) once daily with food. This avoids the flush and hepatic risk of high-dose niacin while still providing NAD+ precursor support.
If your prescriber recommends therapeutic-dose niacin for dyslipidemia (1500 to 2000 mg/day), CoQ10 supplementation is reasonable as an adjunct, but high-dose niacin requires medical supervision and liver function monitoring. It is generally contraindicated alongside statins outside of specialist care due to myopathy risk.
Take CoQ10 with a meal that contains some dietary fat to maximize absorption. Niacin and its alternatives can be taken with or without food, though the flush from nicotinic acid is often reduced by taking it with food.
Which specific products are affected?
NAD+ precursor supplements include plain nicotinamide, nicotinamide riboside (Niagen), and nicotinamide mononucleotide (NMN). CoQ10 is sold as ubiquinone (cheaper, less bioavailable) and ubiquinol (the reduced form, better absorbed, especially after age 40). Look for ubiquinol softgels in oil rather than dry powder capsules.
Combination longevity products often pair nicotinamide riboside with pterostilbene or resveratrol, and CoQ10 with PQQ or alpha-lipoic acid. These bundles can be convenient but make individual dose adjustment harder.
The bottom line
Low-dose niacin or NAD+ precursors combined with CoQ10 is a logical mitochondrial support stack because they support adjacent steps of the same energy pathway. Avoid high-dose flush niacin without medical supervision, especially if you are on statin therapy. For everyday energy support, the low-dose pairing is well tolerated, has biological plausibility, and complements other longevity-focused interventions such as exercise and adequate sleep.